Ernexa Therapeutics (ERNA) Depreciation & Amortization (IS) (2016 - 2020)
Historic Depreciation & Amortization (IS) for Ernexa Therapeutics (ERNA) over the last 11 years, with Q4 2020 value amounting to $297000.0.
- Ernexa Therapeutics' Depreciation & Amortization (IS) fell 5041.74% to $297000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $1.7 million, marking a year-over-year decrease of 3234.01%. This contributed to the annual value of $1.5 million for FY2020, which is 3889.55% down from last year.
- Latest data reveals that Ernexa Therapeutics reported Depreciation & Amortization (IS) of $297000.0 as of Q4 2020, which was down 5041.74% from $346000.0 recorded in Q3 2020.
- In the past 5 years, Ernexa Therapeutics' Depreciation & Amortization (IS) registered a high of $657000.0 during Q3 2018, and its lowest value of $297000.0 during Q4 2020.
- Over the past 5 years, Ernexa Therapeutics' median Depreciation & Amortization (IS) value was $601000.0 (recorded in 2016), while the average stood at $553526.3.
- Its Depreciation & Amortization (IS) has fluctuated over the past 5 years, first soared by 3204.3% in 2018, then tumbled by 5041.74% in 2020.
- Quarter analysis of 5 years shows Ernexa Therapeutics' Depreciation & Amortization (IS) stood at $601000.0 in 2016, then fell by 13.98% to $517000.0 in 2017, then grew by 20.89% to $625000.0 in 2018, then decreased by 4.16% to $599000.0 in 2019, then crashed by 50.42% to $297000.0 in 2020.
- Its last three reported values are $297000.0 in Q4 2020, $346000.0 for Q3 2020, and $461000.0 during Q1 2020.